Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : GSK crawled time : 21:00 save search
23andMe Reports Third Quarter Fiscal 2024 Financial Results
Published: 2024-02-07 (Crawled : 21:00) - globenewswire.com
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: -0.48%
H: 0.16%
C: 0.0%
financial results
Geron Corporation Announces Appointment of Gaurav Aggarwal, M.D., to its Board of Directors
Published: 2023-11-28 (Crawled : 21:00) - biospace.com/
UNCY | $1.09 -5.63% -5.96% 890K
|
Professional, Scientific, and T...
|
| O: -6.96%
H: 7.9%
C: 3.35%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: -0.51%
H: 0.96%
C: 0.54%
GERN | $3.73 1.36% 1.08% 8.4M
|
Health Technology
|
| O: -1.05%
H: 2.65%
C: 1.06%
corporation
23andMe Reports Second Quarter Fiscal 2024 Financial Results
Published: 2023-11-08 (Crawled : 21:00) - globenewswire.com
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: 0.0%
H: 0.03%
C: -1.71%
financial results
Health And Wellness Food Market to increase by USD 452.93 million between 2022 and 2027, the growth of the naturally health food segment will be significant during the forecast period. - Technavio
Published: 2023-10-25 (Crawled : 21:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: 4.23%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: 0.19%
H: 0.22%
C: -1.22%
health food wellness growth market
Arrowhead Pharmaceuticals Reports Fiscal 2023 Third Quarter Results
Published: 2023-08-07 (Crawled : 21:00) - biospace.com/
TAK | News | $13.16 0.08% 0.53% 1.2M
|
Health Technology
|
| O: 0.62%
H: 0.62%
C: 0.42%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: 0.35%
H: 0.41%
C: 0.41%
ARWR | $22.61 0.36% 0.4% 1.3M
|
Health Technology
|
| O: 0.0%
H: 0.44%
C: -2.65%
pharmaceuticals results
Over-The-Counter Drug Market size to grow by USD 58.54 billion from 2022 to 2027, Abbott Laboratories and Achelios Therapeutics Inc. emerge as key contributors to market growth - Technavio
Published: 2023-05-17 (Crawled : 21:00) - prnewswire.com
RBGPF | $51.61 -0.75% 6.46% 4.7K
|
Consumer Non-Durables
|
| O: -0.55%
H: 2.89%
C: -0.35%
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: -4.32%
H: 1.69%
C: 1.69%
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: -2.3%
RBGLY | $10.35 0.58% -2.05% 990K
|
Manufacturing
|
| O: -0.18%
H: 0.24%
C: -0.08%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: -0.49%
H: 0.42%
C: -0.37%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: -1.55%
H: 0.11%
C: -1.04%
ABT | News | $105.27 -0.6% -0.38% 5.9M
|
Health Technology
|
| O: -0.08%
H: 0.1%
C: -0.24%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: 0.28%
H: 0.31%
C: -0.93%
drug therapeutics growth market
Insights on the Alzheimer's Drugs Global Market to 2027 - Hospital Sector will Capture more Revenue in Upcoming Years
Published: 2023-01-25 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.96%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
PFE A | $25.39 -0.12% 0.24% 31M
|
Health Technology
|
| O: -1.93%
H: 0.23%
C: 0.11%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: -1.97%
H: 0.11%
C: -1.25%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: 0.4%
H: 0.28%
C: 0.08%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.36%
H: 0.34%
C: -0.85%
ABT | News | $105.27 -0.6% -0.38% 5.9M
|
Health Technology
|
| O: 0.23%
H: 0.33%
C: -0.16%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
global alzheimer's market
Analgesics Global Market Report 2022: Increasing Number of Strategic Collaborations and Advancements in Medical Drug Development Present Opportunities
Published: 2023-01-12 (Crawled : 21:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: -0.29%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.13%
H: 0.76%
C: 0.76%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 0.15%
H: 0.65%
C: 0.4%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: 0.14%
H: 0.77%
C: 0.51%
ABT | News | $105.27 -0.6% -0.38% 5.9M
|
Health Technology
|
| O: -0.08%
H: 2.35%
C: 2.01%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
drug global report medical market
Worldwide Vaccines Industry to 2029 - Combination Vaccines Remain a Significant Growth Contributor to Vaccine Spaces
Published: 2023-01-06 (Crawled : 21:00) - prnewswire.com
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
| Email alert
Add to watchlist
MRNA S | $102.0 -1.39% -1.4% 1.4M
|
Health Technology
| Email alert
Add to watchlist
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
vaccine growth
Active Pharmaceutical Ingredient Global Market Report 2023: Featuring Teva Pharmaceutical, Bristol-Myers Squibb, Merck
Published: 2023-01-04 (Crawled : 21:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: -1.77%
H: 0.75%
C: 0.75%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: -1.28%
H: 0.35%
C: -0.29%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -0.59%
H: 0.15%
C: -0.56%
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: -1.21%
H: 0.89%
C: 0.25%
ABBV | News | $164.66 0.25% -0.14% 3.6M
|
Health Technology
|
| O: -0.37%
H: 0.86%
C: 0.25%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: -3.07%
H: 0.0%
C: 0.0%
global active report teva market
Global Central Nervous System Therapeutics Market to Grow at Healthy CAGR Due to Rising Disorder Prevalence & Technical Advancements
Published: 2022-09-19 (Crawled : 21:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: -6.97%
H: 7.7%
C: -0.76%
AZNCF | $138.24 -1.36% -4.19% 800
|
Health Technology
|
| O: -0.34%
H: 6.64%
C: -0.06%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.96%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: -0.82%
H: 0.07%
C: -0.61%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: -0.71%
H: 0.2%
C: -0.23%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -0.42%
H: 0.0%
C: -0.69%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: -1.18%
H: 0.0%
C: 0.0%
BIIB | $190.52 -0.85% -0.84% 1.3M
|
Health Technology
|
| O: -0.71%
H: 0.08%
C: -1.72%
AZN | $68.36 -0.25% -0.25% 3.6M
|
Health Technology
|
| O: -1.16%
H: 0.56%
C: 0.14%
AMGN | $262.75 -0.5% -0.49% 1.4M
|
Health Technology
|
| O: -0.98%
H: 0.65%
C: -0.35%
global system therapeutics market
Global Consumer Healthcare Market to Reach $417.7 Billion by 2026
Published: 2022-08-09 (Crawled : 21:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: -2.04%
H: 7.16%
C: 1.71%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -6.43%
H: 0.0%
C: -6.31%
TEVA | $12.78 -3.03% -1.8% 8.4M
|
Health Technology
|
| O: 0.82%
H: 1.26%
C: 0.99%
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
HLF | $8.59 4.37% 0.0% 2.8M
|
Distribution Services
|
| O: 2.2%
H: 2.8%
C: 1.97%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: -2.15%
H: 0.41%
C: -2.22%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: -4.06%
H: 0.0%
C: 0.0%
global market
CureVac besetzt die Stelle des Chief Development Officers neu – Myriam Mendila folgt auf Klaus Edvardsen
Published: 2022-06-08 (Crawled : 21:00) - curevac.com
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: -0.05%
H: 0.0%
C: -2.17%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: -0.9%
H: 0.52%
C: -1.74%
CVAC | News | $2.44 -5.06% -5.33% 670K
|
Health Technology
|
| O: -0.3%
H: 0.79%
C: -4.75%
CureVac beschleunigt Onkologie-Strategie mit Übernahme von Frame Cancer Therapeutics und fügt neuartige Antigen-Entdeckungsplattform hinzu
Published: 2022-06-08 (Crawled : 21:00) - curevac.com
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: -0.05%
H: 0.0%
C: -2.17%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: -0.9%
H: 0.52%
C: -1.74%
CVAC | News | $2.44 -5.06% -5.33% 670K
|
Health Technology
|
| O: -0.3%
H: 0.79%
C: -4.75%
therapeutics cancer
MacroGenics Announces Appointment of William Heiden to Board of Directors
Published: 2022-05-23 (Crawled : 21:00) - biospace.com/
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: 3.85%
H: 4.48%
C: 4.48%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: 0.0%
MGNX | $16.07 -0.19% -0.12% 660K
|
Health Technology
|
| O: 0.0%
H: 3.52%
C: -0.5%
ATRA | $0.6917 -3.25% -3.35% 770K
|
Health Technology
|
| O: 1.74%
H: 1.52%
C: -5.14%
BioMarin Hires Pharmaceutical Industry Leaders in Marketing and Accounting to Fill Strategic Roles Supporting Company's Growth Plans
Published: 2022-05-05 (Crawled : 21:00) - investors.biomarin.com
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: -1.11%
H: 2.28%
C: -0.39%
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: -10.81%
H: 0.0%
C: 0.0%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: -1.32%
H: 0.75%
C: 0.2%
BMRN S | $90.07 -0.44% -0.43% 780K
|
Health Technology
|
| O: -1.18%
H: 1.07%
C: -2.15%
growth
Worldwide T-cell Lymphoma Industry to 2028 - Featuring Genmab, Seagen and GlaxoSmithKline Among Others
Published: 2022-04-28 (Crawled : 21:00) - prnewswire.com
GNMSF | $290.38 3.33% 3.83% 220
|
Health Technology
|
| O: 2.93%
H: 1.47%
C: 1.33%
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.05%
H: 0.0%
C: -0.99%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 0.19%
H: 0.59%
C: -1.36%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: 0.89%
H: 0.0%
C: 0.0%
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: -3.61%
H: 3.02%
C: 2.02%
BHC | $8.6 -0.69% 0.0% 2.2M
|
Health Technology
|
| O: -1.67%
H: 0.0%
C: 0.0%
GMAB | $28.33 -0.7% -0.74% 220K
|
Health Technology
|
| O: 1.4%
H: 0.82%
C: -1.07%
t-cell
The Worldwide Shingles Vaccine Industry is Expected to Reach $6.35 Billion by 2028
Published: 2022-04-13 (Crawled : 21:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: -3.1%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: -0.38%
H: 0.0%
C: 0.0%
vaccine
Insights on the Liver Disease Treatment Global Market to 2027 - by Treatment Type, Disease Type, End-user and Region
Published: 2022-04-12 (Crawled : 21:00) - prnewswire.com
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: 1.76%
H: 0.35%
C: 0.35%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.15%
H: 0.0%
C: -4.71%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: -0.83%
ALPMY | $9.47 0.11% -1.11% 520K
|
Manufacturing
|
| O: 2.3%
H: 0.55%
C: 0.36%
VTRS | $11.12 0.18% 0.09% 2.3M
|
Health Technology
|
| O: 0.37%
H: 2.99%
C: 2.61%
TAK | News | $13.16 0.08% 0.53% 1.2M
|
Health Technology
|
| O: -0.2%
H: 1.83%
C: 1.83%
NVS | $92.57 -0.55% 0.27% 840K
|
Health Technology
|
| O: 0.12%
H: 0.44%
C: 0.17%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: -0.24%
H: 0.45%
C: 0.39%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: -0.26%
H: 0.33%
C: -1.5%
BMY | $48.3 0.96% 0.33% 8.9M
|
Health Technology
|
| O: 0.24%
H: 0.53%
C: 0.18%
ABBV | News | $164.66 0.25% -0.14% 3.6M
|
Health Technology
|
| O: -1.38%
H: 0.0%
C: -3.67%
ABT | News | $105.27 -0.6% -0.38% 5.9M
|
Health Technology
|
| O: -0.7%
H: 1.91%
C: 1.63%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: 0.77%
H: 0.0%
C: 0.0%
treatment liver disease market
US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA.2 Subvariant
Published: 2022-03-25 (Crawled : 21:00) - biospace.com/
GLAXF | $20.2 0.65% -14.18% 40
|
Health Technology
|
| O: 4.57%
H: 0.0%
C: -3.26%
GSK | $39.27 -0.83% 0.26% 1.9M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
XNCR | $18.95 -0.63% -0.47% 470K
|
Health Technology
|
| O: -0.7%
H: 1.94%
C: -1.47%
VIR | $7.96 -3.52% -3.64% 1.1M
|
Health Technology
|
| O: -1.07%
H: 0.8%
C: -12.62%
SNY | News | $45.39 -1.56% -1.58% 4.3M
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
drug food authorization emergency use authorization
Gainers vs Losers
| 60% | 40% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.